According to Vasta Platform's latest financial reports the company's current revenue (TTM) is $0.28 B. In 2022 the company made a revenue of $0.24 B an increase over the years 2021 revenue that were of $0.17 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.28 B | 14.06% |
2022 | $0.24 B | 43.48% |
2021 | $0.17 B | -8.99% |
2020 | $0.18 B | -24.01% |
2019 | $0.24 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Verastem Oncology
VSTM | N/A | N/A | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $25.72 M | -90.87% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | $1.02 B | 263.45% | ๐บ๐ธ USA |